It seems we can’t find what you’re looking for. Perhaps searching can help.
1843 - 1984
London Health Sciences Centre – TRITON 3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician’s Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency